Abstract
Background
When reversing the hard-soft articulation in inverse shoulder replacement, i.e. hard inlay and soft glenosphere (cf. Figure 1), the tribological behaviour of such a pairing has to be tested thoroughly. Therefore, two hard materials for the inlay, CoCr alloy and alumina toughened zirconia ceramic (ceramys®) articulating on two soft materials, conventional UHMWPE and vitamin E stabilised, highly cross-linked PE (vitamys®) were tested in a joint simulator.
Methods
The simulator tests were performed at Endolab GmbH, Rosenheim, Germany, analogue to standardised gravimetric wear tests for hip prosthesis (ISO 14242-1) with load and motion curves adapted to the shoulder. The test parameters differing from the standard were the maximum force (1.0 kN) and the range of motion. A servo-hydraulic six station joint simulator (EndoLab) was used to run the tests up to 5*106 cycles with diluted calf serum at 37° C as lubricant. Visual inspection and mass measurements were done at 0.1, 0.5, 1, 2, 3, 4 and 5 million cycles using a high precision scale and a stereo microscope, respectivly.
Results
The wear rates measured in the simulator are summarised in the table below and illustrated in Figure 2.
The simulator wear rate of the standard articulation CoCr – UHMWPE is similar to that found in the corresponding pairing for hip endoprosthesis, although the articulation diameter of the glenospheres tested is larger (42 mm compared to 28 – 32 mm in hip joints). Replacing UHMWPE by the cross-linked vitamys®, the wear rate is reduced to about 1/3 for both hard counterparts, CoCr and ceramys®, respectively. Replacing the CoCr inlay by a part made from ceramys® lowers wear by about 37 % in articulation against UHMWPE. This difference is significant (p = 0.002, significance level 5 %). And comparing CoCr and ceramys® against vitamys®, yields a reduction of about 44 %. Which is significant again (p = 0.015, significance level 5 %). The lowest wear rate, with a reduction of about 80 % compared to the standard CoCr – UHMWPE, exhibits the pairing of both advanced materials, ceramys® – vitamys®.
Conclusions
Long-term clinical follow-up will confirm if this in-vitro wear reduction leads to longer in-vivo survival of reverse total shoulder arthroplasty. Such a study is under ethic approval, currently. However, the ceramys® inlay offers the benefits of a nickel free inverse shoulder replacement with less x-ray opacity, compared to CoCr.
To view tables/figures, please contact authors directly.
